Wei Wang

机构：University of Science and Technology of China, Wuhan University, Shanghai Genon Biological Products (China), Anhui Provincial Hospital, Renmin Hospital of Wuhan University, Chongqing Municipal Government, Chongqing Municipal Health Commission · ORCID：0000-0001-7838-2430

发表论文 59 篇 · 总被引 3171 次 · h-index 22

代表论文

• Eriocitrin attenuates sepsis-induced acute lung injury in mice by regulating MKP1/MAPK pathway mediated-glycolysis (2023 · International Immunopharmacology · 被引 43)
• PD-1/CD80+ small extracellular vesicles from immunocytes induce cold tumours featured with enhanced adaptive immunosuppression (2024 · Nature Communications · 被引 29)
• Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis (2024 · Oncogene · 被引 24)
• PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification (2023 · Frontiers in Immunology · 被引 20)
• Inhibition of inflammatory factor TNF-α by ferrostatin-1 in microglia regulates necroptosis of oligodendrocyte precursor cells (2023 · Neuroreport · 被引 16)
• Innovative Oral Nano/Gene Delivery System Based on Engineered Modified Saccharomyces cerevisiae for Colorectal Cancer Therapy (2024 · ACS Nano · 被引 14)